vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Claros Mortgage Trust, Inc. (CMTG). Click either name above to swap in a different company.
Claros Mortgage Trust, Inc. is the larger business by last-quarter revenue ($46.7M vs $44.9M, roughly 1.0× AbCellera Biologics Inc.). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -468.9%, a 449.0% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -22.4%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -10.9%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Claros Mortgage Trust, Inc. is a U.S.-based real estate investment trust that invests in diversified mortgage-related assets, including residential and commercial mortgage loans and mortgage-backed securities. It pursues stable, risk-adjusted long-term returns for shareholders via rigorous asset evaluation and active portfolio management.
ABCL vs CMTG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $46.7M |
| Net Profit | $-8.9M | $-219.2M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | — |
| Net Margin | -19.9% | -468.9% |
| Revenue YoY | 788.4% | -22.4% |
| Net Profit YoY | 73.9% | -117.7% |
| EPS (diluted) | $-0.03 | $-1.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $46.7M | ||
| Q3 25 | $9.0M | $46.1M | ||
| Q2 25 | $17.1M | $51.6M | ||
| Q1 25 | $4.2M | $43.4M | ||
| Q4 24 | $5.0M | $60.2M | ||
| Q3 24 | $6.5M | $64.9M | ||
| Q2 24 | $7.3M | $64.5M | ||
| Q1 24 | $10.0M | $58.8M |
| Q4 25 | $-8.9M | $-219.2M | ||
| Q3 25 | $-57.1M | $-9.5M | ||
| Q2 25 | $-34.7M | $-181.7M | ||
| Q1 25 | $-45.6M | $-78.6M | ||
| Q4 24 | — | $-100.7M | ||
| Q3 24 | $-51.1M | $-56.2M | ||
| Q2 24 | $-36.9M | $-11.6M | ||
| Q1 24 | $-40.6M | $-52.8M |
| Q4 25 | -63.7% | — | ||
| Q3 25 | -851.8% | — | ||
| Q2 25 | -290.2% | — | ||
| Q1 25 | -1479.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1439.4% | — | ||
| Q2 24 | -1276.2% | — | ||
| Q1 24 | -551.5% | — |
| Q4 25 | -19.9% | -468.9% | ||
| Q3 25 | -637.8% | -20.7% | ||
| Q2 25 | -203.3% | -351.9% | ||
| Q1 25 | -1077.2% | -181.3% | ||
| Q4 24 | — | -167.2% | ||
| Q3 24 | -785.4% | -86.7% | ||
| Q2 24 | -504.3% | -17.9% | ||
| Q1 24 | -408.0% | -89.7% |
| Q4 25 | $-0.03 | $-1.56 | ||
| Q3 25 | $-0.19 | $-0.07 | ||
| Q2 25 | $-0.12 | $-1.30 | ||
| Q1 25 | $-0.15 | $-0.56 | ||
| Q4 24 | — | $-0.72 | ||
| Q3 24 | $-0.17 | $-0.40 | ||
| Q2 24 | $-0.13 | $-0.09 | ||
| Q1 24 | $-0.14 | $-0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $173.2M |
| Total DebtLower is stronger | — | $3.2B |
| Stockholders' EquityBook value | $966.9M | $1.5B |
| Total Assets | $1.4B | $4.7B |
| Debt / EquityLower = less leverage | — | 2.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $173.2M | ||
| Q3 25 | $83.2M | $339.5M | ||
| Q2 25 | $92.4M | $209.2M | ||
| Q1 25 | $159.3M | $127.8M | ||
| Q4 24 | $156.3M | $99.1M | ||
| Q3 24 | $126.6M | $113.9M | ||
| Q2 24 | $148.3M | $148.2M | ||
| Q1 24 | $123.6M | $232.5M |
| Q4 25 | — | $3.2B | ||
| Q3 25 | — | $3.7B | ||
| Q2 25 | — | $4.0B | ||
| Q1 25 | — | $4.7B | ||
| Q4 24 | — | $4.9B | ||
| Q3 24 | — | $5.1B | ||
| Q2 24 | — | $5.3B | ||
| Q1 24 | — | $5.5B |
| Q4 25 | $966.9M | $1.5B | ||
| Q3 25 | $964.0M | $1.7B | ||
| Q2 25 | $1.0B | $1.8B | ||
| Q1 25 | $1.0B | $1.9B | ||
| Q4 24 | $1.1B | $2.0B | ||
| Q3 24 | $1.1B | $2.1B | ||
| Q2 24 | $1.1B | $2.2B | ||
| Q1 24 | $1.1B | $2.2B |
| Q4 25 | $1.4B | $4.7B | ||
| Q3 25 | $1.4B | $5.4B | ||
| Q2 25 | $1.4B | $5.8B | ||
| Q1 25 | $1.3B | $6.7B | ||
| Q4 24 | $1.4B | $7.0B | ||
| Q3 24 | $1.4B | $7.3B | ||
| Q2 24 | $1.4B | $7.6B | ||
| Q1 24 | $1.5B | $7.8B |
| Q4 25 | — | 2.06× | ||
| Q3 25 | — | 2.09× | ||
| Q2 25 | — | 2.29× | ||
| Q1 25 | — | 2.42× | ||
| Q4 24 | — | 2.44× | ||
| Q3 24 | — | 2.44× | ||
| Q2 24 | — | 2.46× | ||
| Q1 24 | — | 2.47× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-30.5M |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $-30.5M | ||
| Q3 25 | $-52.6M | $8.8M | ||
| Q2 25 | $-32.4M | $-5.8M | ||
| Q1 25 | $-11.6M | $-35.8M | ||
| Q4 24 | $-108.6M | $84.5M | ||
| Q3 24 | $-28.9M | $39.2M | ||
| Q2 24 | $-30.0M | $5.5M | ||
| Q1 24 | $-41.7M | $21.5M |
| Q4 25 | $-44.6M | — | ||
| Q3 25 | $-61.5M | — | ||
| Q2 25 | $-45.8M | — | ||
| Q1 25 | $-22.2M | — | ||
| Q4 24 | $-187.0M | — | ||
| Q3 24 | $-47.4M | — | ||
| Q2 24 | $-50.1M | — | ||
| Q1 24 | $-65.8M | — |
| Q4 25 | -99.4% | — | ||
| Q3 25 | -687.0% | — | ||
| Q2 25 | -267.9% | — | ||
| Q1 25 | -524.0% | — | ||
| Q4 24 | -3702.8% | — | ||
| Q3 24 | -728.4% | — | ||
| Q2 24 | -683.8% | — | ||
| Q1 24 | -661.5% | — |
| Q4 25 | 21.9% | — | ||
| Q3 25 | 99.7% | — | ||
| Q2 25 | 78.2% | — | ||
| Q1 25 | 251.1% | — | ||
| Q4 24 | 1552.7% | — | ||
| Q3 24 | 284.6% | — | ||
| Q2 24 | 274.6% | — | ||
| Q1 24 | 242.5% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
CMTG
| Real Estate Owned Portfolio | $34.2M | 73% |
| Other | $11.1M | 24% |
| Mixed Use Property Fixed Rents | $1.4M | 3% |
